SPOTLIGHT: $1B program catalogs cancer triggers


An international consortium of researchers has launched a billion-dollar effort to map every way that changes in DNA contributes to the development of tumors. The newly launched International Cancer Genome Consortium says that they hope to complete their work in less than 10 years as they ambitiously map out a project that is being described as the cancer equivalent of the Human Genome Project. Report

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.